SLC7A11 and breast carcinoma: For example, the inhibition of xCT by SAS in human breast cancer cells leads to a decrease in GSH content, which is involved in drug detoxification and elimination, as it combines with anticancer drugs to mediate their export from cells by multidrug resistance proteins.